Bone Therapeutics Business Update for Third Quarter 2017 Read more about Bone Therapeutics Business Update for Third Quarter 2017
Bone Therapeutics and Cellthera Pharm LLC announce intention to collaborate and Bone Therapeutics provides overview of its pipeline Read more about Bone Therapeutics and Cellthera Pharm LLC announce intention to collaborate and Bone Therapeutics provides overview of its pipeline
Bone Therapeutics Launches Equity Placement Read more about Bone Therapeutics Launches Equity Placement
Bone Therapeutics Provides Update on Equity Placement Read more about Bone Therapeutics Provides Update on Equity Placement
Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2018 Read more about Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2018
Bone Therapeutics provides business outlook and announces its financial calendar for 2018 Read more about Bone Therapeutics provides business outlook and announces its financial calendar for 2018
Bone Therapeutics completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB Read more about Bone Therapeutics completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB
Bone Therapeutics strengthens Board with the appointment of Jean Stéphenne as Chairman Read more about Bone Therapeutics strengthens Board with the appointment of Jean Stéphenne as Chairman
Bone Therapeutics Announces Private Placement of Convertible Bonds Read more about Bone Therapeutics Announces Private Placement of Convertible Bonds
Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement Read more about Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement
